Status:
COMPLETED
Effect of Intravenous Nalbuphine on Emergence Agitation
Lead Sponsor:
Assiut University
Conditions:
Postoperative Complications
Eligibility:
All Genders
3-8 years
Phase:
PHASE2
Brief Summary
Our primary objective of this study is to compare the effect of administration of single dose of intravenous nalbuphine given with induction of anesthesia with intravenous nalbuphine given at the end ...
Detailed Description
Postoperative agitation, also referred to as emergence delirium is characterized by mental confusion, irritability, disorientation, inconsolable crying, and increased recovery time in the post anesthe...
Eligibility Criteria
Inclusion
- Age: 3-8 years.
- American Society of Anesthesiologists (ASA) physical status I-II scheduled to undergo repair of rupture globe.
- Gender: both.
Exclusion
- Parent refusal.
- History of developmental delay or mental retardation.
- Known hypersensitivity to any drug used in this study.
- Children with co-morbid conditions like congenital heart disease, respiratory pathology and central nervous system disorders.
Key Trial Info
Start Date :
July 31 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2020
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT03470077
Start Date
July 31 2019
End Date
December 1 2020
Last Update
September 2 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Assiut University Hospital
Asyut, Egypt, 71515